Can­cer test­ing com­pa­ny Freenome to lay off 100 em­ploy­ees

Freenome, a mak­er of blood-based can­cer tests, will lay off more than 100 em­ploy­ees, or 20% of its work­force, a spokesper­son for the com­pa­ny told End­points News.

The job cuts come af­ter Freenome raised $254 mil­lion in fi­nanc­ing in Feb­ru­ary, bring­ing its fund­ing to­tal to $1.3 bil­lion since the com­pa­ny’s found­ing in 2014. A spokesper­son for Freenome said in a state­ment the re­struc­tur­ing will “bet­ter align with our strate­gic pri­or­i­ties.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER